Kwang Hwa Jung

Author PubWeight™ 11.92^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.	Hepatology	2013	1.49
2	MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.	Cancer Lett	2013	1.17
3	Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1/S cell cycle proteins.	PLoS One	2011	1.12
4	DBC1 does not function as a negative regulator of SIRT1 in liver cancer.	Oncol Lett	2012	0.91
5	HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancer.	PLoS One	2012	0.91
6	Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.	Int J Oncol	2009	0.87
7	Targeted inactivation of HDAC2 restores p16INK4a activity and exerts antitumor effects on human gastric cancer.	Mol Cancer Res	2012	0.85
8	Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression.	Oncol Rep	2010	0.84
9	Discriminating the molecular basis of hepatotoxicity using the large-scale characteristic molecular signatures of toxicants by expression profiling analysis.	Toxicology	2008	0.81
10	Systemic cell-cycle suppression by Apicidin, a histone deacetylase inhibitor, in MDA-MB-435 cells.	Int J Mol Med	2009	0.81
11	Identification of characteristic molecular signature for volatile organic compounds in peripheral blood of rat.	Toxicol Appl Pharmacol	2010	0.78
12	Transcriptomic configuration of mouse brain induced by adolescent exposure to 3,4-methylenedioxymethamphetamine.	Toxicol Appl Pharmacol	2009	0.76
13	Identification of post-generation effect of 3,4-methylenedioxymethamphetamine on the mouse brain by large-scale gene expression analysis.	Toxicol Lett	2010	0.76
14	Down-regulation of transforming growth factor beta receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity.	Oncol Rep	2009	0.75